HYDROXYCHLOROQUINE DIPHOSPHATE for Mobility decreased: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 5 adverse event reports in the FDA FAERS database where HYDROXYCHLOROQUINE DIPHOSPHATE was used for Mobility decreased.
Most Reported Side Effects for HYDROXYCHLOROQUINE DIPHOSPHATE
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Drug ineffective | 1,220 | 65.2% | 63 | 253 |
| Rheumatoid arthritis | 914 | 48.9% | 69 | 212 |
| Pain | 633 | 33.9% | 69 | 189 |
| Drug intolerance | 607 | 32.5% | 62 | 184 |
| Joint swelling | 559 | 29.9% | 69 | 175 |
| Fatigue | 523 | 28.0% | 65 | 187 |
| Arthralgia | 487 | 26.0% | 62 | 157 |
| Contraindicated product administered | 463 | 24.8% | 56 | 153 |
| Abdominal discomfort | 456 | 24.4% | 63 | 152 |
| Off label use | 441 | 23.6% | 72 | 176 |
| Treatment failure | 421 | 22.5% | 50 | 129 |
| Arthropathy | 409 | 21.9% | 66 | 175 |
| Alopecia | 398 | 21.3% | 62 | 121 |
| Swelling | 386 | 20.6% | 61 | 114 |
| Condition aggravated | 384 | 20.5% | 63 | 125 |
Other Indications for HYDROXYCHLOROQUINE DIPHOSPHATE
Rheumatoid arthritis (939)
Product used for unknown indication (709)
Systemic lupus erythematosus (57)
Coronavirus infection (26)
Covid-19 (14)
Polyarthritis (9)
Sjogren's syndrome (8)
Lupus nephritis (6)
Joint stiffness (5)
Pain (5)
Other Drugs Used for Mobility decreased
DALFAMPRIDINE (74)
LEFLUNOMIDE (48)
NAPROXEN (48)
DICLOFENAC (46)
GOLD (46)
ADALIMUMAB (45)
IBUPROFEN (45)
ETANERCEPT (43)
ASPIRIN (41)
METHOTREXATE (39)